￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Instructions on whether genetic testing is required before use of Sotolaxib (AMG 510)

2026-02-01 22:25:32

Check Details
Sharing of formal purchase channels for Adagraxibu (Krazati) and practical methods to identify authenticity

2026-02-01 22:25:32

Check Details
Common side effects of Pimitespib and how to prevent and treat them

2026-02-01 22:25:32

Check Details
Full analysis of Afatinib production countries and manufacturer information

2026-02-01 22:25:32

Check Details
The side effects and treatment strategies of taking DaliRasheng (Keweike)

2026-02-01 22:25:32

Check Details
Evaluation of the real efficacy and clinical application of Lynparza

2026-02-01 22:25:32

Check Details
Which diseases can be treated by Venetoclax/Venetoclax (Vekela) and its efficacy evaluation

2026-02-01 22:25:32

Check Details
Asciminib monthly cost and reference price after medical insurance reimbursement

2026-02-01 22:25:32

Check Details
Analysis on whether it is necessary to adhere to the medication for a long time after taking ritexitinib (Lefenox)

2026-02-01 22:25:32

Check Details
Price and medical insurance reimbursement reference of sparsentan in China

2026-02-01 22:25:32

Check Details
Analysis of the therapeutic effect of Ixazomib (Enleri) and real clinical feedback from patients

2026-02-01 22:25:32

Check Details
Is rubitin/rubicatin (Zanbiga) a chemotherapy drug or a targeted drug and analysis of its mechanism

2026-02-01 22:25:32

Check Details
Category
相关知识